Literature DB >> 24963167

Human in vitro oocyte maturation is not associated with increased imprinting error rates at LIT1, SNRPN, PEG3 and GTL2.

J Kuhtz1, S Romero2, M De Vos2, J Smitz2, T Haaf1, E Anckaert3.   

Abstract

STUDY QUESTION: Does in vitro maturation (IVM) of cumulus-enclosed germinal vesicle (GV) stage oocytes retrieved from small antral follicles in minimally stimulated cycles without an ovulatory hCG dose induce imprinting errors at LIT1, SNRPN, PEG3 and GTL2 in human oocytes? SUMMARY ANSWER: There is no significant increase in imprinting mutations at LIT1, SNRPN, PEG3 and GTL2 after IVM of cumulus-enclosed GV oocytes from small antral follicles in minimally stimulated cycles without hCG priming. WHAT IS KNOWN ALREADY: Animal models have generally demonstrated correct methylation imprint establishment for in vitro grown and matured oocytes. For human IVM, well-designed studies allowing conclusions on imprint establishment are currently not available. STUDY DESIGN, SIZE, DURATION: Immature oocyte-cumulus complexes from 2 to 9 mm follicles were retrieved in polycystic ovary syndrome (PCOS) subjects in minimally stimulated cycles without hCG priming and matured in vitro. In vivo grown oocytes were retrieved after conventional ovarian stimulation for IVF/ICSI or after ovulation induction. Imprinting error rates at three maternally methylated (LIT1, SNRPN and PEG3) and one paternally methylated (GTL2) imprinted genes were compared in 71 in vitro and 38 in vivo matured oocytes. PARTICIPANTS/MATERIALS, SETTING,
METHODS: The limiting dilution bisulfite sequencing technique was applied, allowing increased sensitivity based on multiplex PCR for the imprinted genes and the inclusion of non-imprinted marker genes for cumulus cell DNA contamination. MAIN RESULTS AND THE ROLE OF CHANCE: In vitro as well as in vivo matured oocytes showed only a few abnormal alleles, consistent with epimutations. The abnormalities were more frequent in immature than in mature oocytes for both groups, although no significant difference was reached. There was no statistically significant increase in imprinting errors in IVM oocytes. LIMITATIONS, REASONS FOR CAUTION: This single cell methylation analysis was restricted to a number of well-selected imprinted genes. Genome-wide methylation analysis of single human oocytes is currently not possible. WIDER IMPLICATIONS OF THE
FINDINGS: IVM is a patient-friendly alternative to conventional ovarian stimulation in PCOS patients and is associated with reduced gonadotrophin costs and avoidance of OHSS. The results of this study show for the first time that optimized human IVM procedures have no significant effects on the establishment of maternal DNA methylation patterns at LIT1, SNRPN, PEG3 and GTL2. STUDY FUNDING/COMPETING INTERESTS: This study was supported by research funds from Agentschap voor Innovatie door Wetenschap en Technologie (IWT-TBM 110680), Wetenschappelijk Fonds Willy Gepts (WFWG 2011) and German Research Foundation (HA 1374/12-2). There are no competing interests.
© The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  DNA methylation; IVM; genomic imprinting; oocyte

Mesh:

Substances:

Year:  2014        PMID: 24963167     DOI: 10.1093/humrep/deu155

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  16 in total

1.  Random start or emergency IVF/in vitro maturation: a new rapid approach to fertility preservation.

Authors:  David Mark Robertson; Robert B Gilchrist; William Leigh Ledger; Angela Baerwald
Journal:  Womens Health (Lond)       Date:  2016-06-01

Review 2.  Preserving Oocytes in Oncofertility†.

Authors:  Maria McClam; Shuo Xiao
Journal:  Biol Reprod       Date:  2022-02-22       Impact factor: 4.285

Review 3.  In vivo and in vitro postovulatory aging: when time works against oocyte quality?

Authors:  Valentina Di Nisio; Sevastiani Antonouli; Pauliina Damdimopoulou; Andres Salumets; Sandra Cecconi
Journal:  J Assist Reprod Genet       Date:  2022-03-21       Impact factor: 3.357

Review 4.  Postnatal oogenesis in humans: a review of recent findings.

Authors:  Irma Virant-Klun
Journal:  Stem Cells Cloning       Date:  2015-03-20

5.  Imprinting alterations in sperm may not significantly influence ART outcomes and imprinting patterns in the cord blood of offspring.

Authors:  Li Tang; Zichao Liu; Ruopeng Zhang; Cunmei Su; Wenjuan Yang; Youlin Yao; Shuhua Zhao
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

6.  Genome-wide, Single-Cell DNA Methylomics Reveals Increased Non-CpG Methylation during Human Oocyte Maturation.

Authors:  Bo Yu; Xiao Dong; Silvia Gravina; Önder Kartal; Timothy Schimmel; Jacques Cohen; Drew Tortoriello; Raifa Zody; R David Hawkins; Jan Vijg
Journal:  Stem Cell Reports       Date:  2017-06-22       Impact factor: 7.765

7.  Gene expression profiling of human blastocysts from in vivo and 'rescue IVM' with or without melatonin treatment.

Authors:  Yan Hao; Zhiguo Zhang; Dan Han; Yunxia Cao; Ping Zhou; Zhaolian Wei; Mingrong Lv; Dawei Chen
Journal:  Mol Med Rep       Date:  2017-06-09       Impact factor: 2.952

Review 8.  Perspectives on the development and future of oocyte IVM in clinical practice.

Authors:  Michel De Vos; Michaël Grynberg; Tuong M Ho; Ye Yuan; David F Albertini; Robert B Gilchrist
Journal:  J Assist Reprod Genet       Date:  2021-07-03       Impact factor: 3.412

9.  Oxygen concentration affects de novo DNA methylation and transcription in in vitro cultured oocytes.

Authors:  Florence Naillat; Heba Saadeh; Joanna Nowacka-Woszuk; Lenka Gahurova; Fatima Santos; Shin-Ichi Tomizawa; Gavin Kelsey
Journal:  Clin Epigenetics       Date:  2021-06-28       Impact factor: 6.551

10.  Hypermethylation of the non-imprinted maternal MEG3 and paternal MEST alleles is highly variable among normal individuals.

Authors:  Larissa Haertle; Anna Maierhofer; Julia Böck; Harald Lehnen; Yvonne Böttcher; Matthias Blüher; Martin Schorsch; Ramya Potabattula; Nady El Hajj; Silke Appenzeller; Thomas Haaf
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.